BRSYF
Price
$3.40
Change
-$2.39 (-41.28%)
Updated
Apr 11 closing price
Capitalization
39.9M
RSCF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
8.35M
Interact to see
Advertisement

BRSYF vs RSCF

Header iconBRSYF vs RSCF Comparison
Open Charts BRSYF vs RSCFBanner chart's image
Brainsway
Price$3.40
Change-$2.39 (-41.28%)
Volume$900
Capitalization39.9M
Reflect Scientific
Price$0.06
Change-$0.00 (-0.00%)
Volume$138.75K
Capitalization8.35M
BRSYF vs RSCF Comparison Chart in %
Loading...
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRSYF vs. RSCF commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSYF is a Hold and RSCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BRSYF: $3.40 vs. RSCF: $0.05)
Brand notoriety: BRSYF and RSCF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRSYF: 100% vs. RSCF: 197%
Market capitalization -- BRSYF: $39.9M vs. RSCF: $8.35M
BRSYF [@Medical Specialties] is valued at $39.9M. RSCF’s [@Medical Specialties] market capitalization is $8.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRSYF’s FA Score shows that 0 FA rating(s) are green whileRSCF’s FA Score has 1 green FA rating(s).

  • BRSYF’s FA Score: 0 green, 5 red.
  • RSCF’s FA Score: 1 green, 4 red.
According to our system of comparison, RSCF is a better buy in the long-term than BRSYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRSYF’s TA Score shows that 2 TA indicator(s) are bullish while RSCF’s TA Score has 1 bullish TA indicator(s).

  • BRSYF’s TA Score: 2 bullish, 1 bearish.
  • RSCF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, BRSYF is a better buy in the short-term than RSCF.

Price Growth

BRSYF (@Medical Specialties) experienced а 0.00% price change this week, while RSCF (@Medical Specialties) price change was +1.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.51%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was +2.89%.

Industries' Descriptions

@Medical Specialties (+2.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRSYF($39.9M) has a higher market cap than RSCF($8.35M). RSCF YTD gains are higher at: 30.952 vs. BRSYF (7.937). RSCF has higher annual earnings (EBITDA): -207.37K vs. BRSYF (-13.7M). BRSYF has more cash in the bank: 44.3M vs. RSCF (1.2M). RSCF has less debt than BRSYF: RSCF (42.2K) vs BRSYF (754K). BRSYF has higher revenues than RSCF: BRSYF (25.8M) vs RSCF (1.53M).
BRSYFRSCFBRSYF / RSCF
Capitalization39.9M8.35M478%
EBITDA-13.7M-207.37K6,607%
Gain YTD7.93730.95226%
P/E RatioN/A50.76-
Revenue25.8M1.53M1,687%
Total Cash44.3M1.2M3,695%
Total Debt754K42.2K1,787%
FUNDAMENTALS RATINGS
BRSYF vs RSCF: Fundamental Ratings
BRSYF
RSCF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
7890
PRICE GROWTH RATING
1..100
5948
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a16

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRSYF's Valuation (68) in the null industry is in the same range as RSCF (73). This means that BRSYF’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's Profit vs Risk Rating (99) in the null industry is in the same range as BRSYF (100). This means that RSCF’s stock grew similarly to BRSYF’s over the last 12 months.

BRSYF's SMR Rating (78) in the null industry is in the same range as RSCF (90). This means that BRSYF’s stock grew similarly to RSCF’s over the last 12 months.

RSCF's Price Growth Rating (48) in the null industry is in the same range as BRSYF (59). This means that RSCF’s stock grew similarly to BRSYF’s over the last 12 months.

RSCF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for BRSYF (100). This means that RSCF’s stock grew significantly faster than BRSYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRSYFRSCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPD3.950.47
+13.42%
CompuMed, Inc.
SILEF0.16N/A
+1.27%
Silver Elephant Mining Corp.
SGAPY30.090.19
+0.64%
Singapore Telecommunications Ltd.
BIOGY8.98N/A
N/A
Biogaia AB
CFEIY7.68N/A
N/A
China Feihe Limited

BRSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
61%
Loosely correlated
N/A
KSRBF - BRSYF
51%
Loosely correlated
N/A
VERO - BRSYF
28%
Poorly correlated
-0.91%
WUXIF - BRSYF
27%
Poorly correlated
N/A
FSPKF - BRSYF
25%
Poorly correlated
N/A
More

RSCF and

Correlation & Price change

A.I.dvisor tells us that RSCF and MXCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCF and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCF
1D Price
Change %
RSCF100%
N/A
MXCT - RSCF
22%
Poorly correlated
-4.35%
BRSYF - RSCF
20%
Poorly correlated
N/A
RSMDF - RSCF
10%
Poorly correlated
N/A
RYLPF - RSCF
6%
Poorly correlated
+2.78%
PFGTF - RSCF
3%
Poorly correlated
N/A
More